Cargando…
The Effects of Low Levels of Dystrophin on Mouse Muscle Function and Pathology
Duchenne muscular dystrophy (DMD) is a severe progressive muscular disorder caused by reading frame disrupting mutations in the DMD gene, preventing the synthesis of functional dystrophin. As dystrophin provides muscle fiber stability during contractions, dystrophin negative fibers are prone to exer...
Autores principales: | , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3281102/ https://www.ncbi.nlm.nih.gov/pubmed/22359642 http://dx.doi.org/10.1371/journal.pone.0031937 |
_version_ | 1782223921001529344 |
---|---|
author | van Putten, Maaike Hulsker, Margriet Nadarajah, Vishna Devi van Heiningen, Sandra H. van Huizen, Ella van Iterson, Maarten Admiraal, Peter Messemaker, Tobias den Dunnen, Johan T. 't Hoen, Peter A. C. Aartsma-Rus, Annemieke |
author_facet | van Putten, Maaike Hulsker, Margriet Nadarajah, Vishna Devi van Heiningen, Sandra H. van Huizen, Ella van Iterson, Maarten Admiraal, Peter Messemaker, Tobias den Dunnen, Johan T. 't Hoen, Peter A. C. Aartsma-Rus, Annemieke |
author_sort | van Putten, Maaike |
collection | PubMed |
description | Duchenne muscular dystrophy (DMD) is a severe progressive muscular disorder caused by reading frame disrupting mutations in the DMD gene, preventing the synthesis of functional dystrophin. As dystrophin provides muscle fiber stability during contractions, dystrophin negative fibers are prone to exercise-induced damage. Upon exhaustion of the regenerative capacity, fibers will be replaced by fibrotic and fat tissue resulting in a progressive loss of function eventually leading to death in the early thirties. With several promising approaches for the treatment of DMD aiming at dystrophin restoration in clinical trials, there is an increasing need to determine more precisely which dystrophin levels are sufficient to restore muscle fiber integrity, protect against muscle damage and improve muscle function. To address this we generated a new mouse model (mdx-Xist (Δhs)) with varying, low dystrophin levels (3–47%, mean 22.7%, stdev 12.1, n = 24) due to skewed X-inactivation. Longitudinal sections revealed that within individual fibers, some nuclei did and some did not express dystrophin, resulting in a random, mosaic pattern of dystrophin expression within fibers. Mdx-Xist (Δhs), mdx and wild type females underwent a 12 week functional test regime consisting of different tests to assess muscle function at base line, or after chronic treadmill running exercise. Overall, mdx-Xist (Δhs) mice with 3–14% dystrophin outperformed mdx mice in the functional tests. Improved histopathology was observed in mice with 15–29% dystrophin and these levels also resulted in normalized expression of pro-inflammatory biomarker genes, while for other parameters >30% of dystrophin was needed. Chronic exercise clearly worsened pathology, which needed dystrophin levels >20% for protection. Based on these findings, we conclude that while even dystrophin levels below 15% can improve pathology and performance, levels of >20% are needed to fully protect muscle fibers from exercise-induced damage. |
format | Online Article Text |
id | pubmed-3281102 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2012 |
publisher | Public Library of Science |
record_format | MEDLINE/PubMed |
spelling | pubmed-32811022012-02-22 The Effects of Low Levels of Dystrophin on Mouse Muscle Function and Pathology van Putten, Maaike Hulsker, Margriet Nadarajah, Vishna Devi van Heiningen, Sandra H. van Huizen, Ella van Iterson, Maarten Admiraal, Peter Messemaker, Tobias den Dunnen, Johan T. 't Hoen, Peter A. C. Aartsma-Rus, Annemieke PLoS One Research Article Duchenne muscular dystrophy (DMD) is a severe progressive muscular disorder caused by reading frame disrupting mutations in the DMD gene, preventing the synthesis of functional dystrophin. As dystrophin provides muscle fiber stability during contractions, dystrophin negative fibers are prone to exercise-induced damage. Upon exhaustion of the regenerative capacity, fibers will be replaced by fibrotic and fat tissue resulting in a progressive loss of function eventually leading to death in the early thirties. With several promising approaches for the treatment of DMD aiming at dystrophin restoration in clinical trials, there is an increasing need to determine more precisely which dystrophin levels are sufficient to restore muscle fiber integrity, protect against muscle damage and improve muscle function. To address this we generated a new mouse model (mdx-Xist (Δhs)) with varying, low dystrophin levels (3–47%, mean 22.7%, stdev 12.1, n = 24) due to skewed X-inactivation. Longitudinal sections revealed that within individual fibers, some nuclei did and some did not express dystrophin, resulting in a random, mosaic pattern of dystrophin expression within fibers. Mdx-Xist (Δhs), mdx and wild type females underwent a 12 week functional test regime consisting of different tests to assess muscle function at base line, or after chronic treadmill running exercise. Overall, mdx-Xist (Δhs) mice with 3–14% dystrophin outperformed mdx mice in the functional tests. Improved histopathology was observed in mice with 15–29% dystrophin and these levels also resulted in normalized expression of pro-inflammatory biomarker genes, while for other parameters >30% of dystrophin was needed. Chronic exercise clearly worsened pathology, which needed dystrophin levels >20% for protection. Based on these findings, we conclude that while even dystrophin levels below 15% can improve pathology and performance, levels of >20% are needed to fully protect muscle fibers from exercise-induced damage. Public Library of Science 2012-02-16 /pmc/articles/PMC3281102/ /pubmed/22359642 http://dx.doi.org/10.1371/journal.pone.0031937 Text en van Putten et al. http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are properly credited. |
spellingShingle | Research Article van Putten, Maaike Hulsker, Margriet Nadarajah, Vishna Devi van Heiningen, Sandra H. van Huizen, Ella van Iterson, Maarten Admiraal, Peter Messemaker, Tobias den Dunnen, Johan T. 't Hoen, Peter A. C. Aartsma-Rus, Annemieke The Effects of Low Levels of Dystrophin on Mouse Muscle Function and Pathology |
title | The Effects of Low Levels of Dystrophin on Mouse Muscle Function and Pathology |
title_full | The Effects of Low Levels of Dystrophin on Mouse Muscle Function and Pathology |
title_fullStr | The Effects of Low Levels of Dystrophin on Mouse Muscle Function and Pathology |
title_full_unstemmed | The Effects of Low Levels of Dystrophin on Mouse Muscle Function and Pathology |
title_short | The Effects of Low Levels of Dystrophin on Mouse Muscle Function and Pathology |
title_sort | effects of low levels of dystrophin on mouse muscle function and pathology |
topic | Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3281102/ https://www.ncbi.nlm.nih.gov/pubmed/22359642 http://dx.doi.org/10.1371/journal.pone.0031937 |
work_keys_str_mv | AT vanputtenmaaike theeffectsoflowlevelsofdystrophinonmousemusclefunctionandpathology AT hulskermargriet theeffectsoflowlevelsofdystrophinonmousemusclefunctionandpathology AT nadarajahvishnadevi theeffectsoflowlevelsofdystrophinonmousemusclefunctionandpathology AT vanheiningensandrah theeffectsoflowlevelsofdystrophinonmousemusclefunctionandpathology AT vanhuizenella theeffectsoflowlevelsofdystrophinonmousemusclefunctionandpathology AT vanitersonmaarten theeffectsoflowlevelsofdystrophinonmousemusclefunctionandpathology AT admiraalpeter theeffectsoflowlevelsofdystrophinonmousemusclefunctionandpathology AT messemakertobias theeffectsoflowlevelsofdystrophinonmousemusclefunctionandpathology AT dendunnenjohant theeffectsoflowlevelsofdystrophinonmousemusclefunctionandpathology AT thoenpeterac theeffectsoflowlevelsofdystrophinonmousemusclefunctionandpathology AT aartsmarusannemieke theeffectsoflowlevelsofdystrophinonmousemusclefunctionandpathology AT vanputtenmaaike effectsoflowlevelsofdystrophinonmousemusclefunctionandpathology AT hulskermargriet effectsoflowlevelsofdystrophinonmousemusclefunctionandpathology AT nadarajahvishnadevi effectsoflowlevelsofdystrophinonmousemusclefunctionandpathology AT vanheiningensandrah effectsoflowlevelsofdystrophinonmousemusclefunctionandpathology AT vanhuizenella effectsoflowlevelsofdystrophinonmousemusclefunctionandpathology AT vanitersonmaarten effectsoflowlevelsofdystrophinonmousemusclefunctionandpathology AT admiraalpeter effectsoflowlevelsofdystrophinonmousemusclefunctionandpathology AT messemakertobias effectsoflowlevelsofdystrophinonmousemusclefunctionandpathology AT dendunnenjohant effectsoflowlevelsofdystrophinonmousemusclefunctionandpathology AT thoenpeterac effectsoflowlevelsofdystrophinonmousemusclefunctionandpathology AT aartsmarusannemieke effectsoflowlevelsofdystrophinonmousemusclefunctionandpathology |